Huons Co., Ltd.

Research Huons Co., Ltd. (243070.KQ) on Bullrun: market cap KRW 210.31B, dividend yield 6.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 210.31B; dividend yield is 6.5%.

Peer valuation comparison

Latest dividend yield is 6.48% versus a Healthcare sector median of 2.4% (170.0% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 210.31Bn/a6.5%1170

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1170 KRW, yield 6.5%.

About Huons Co., Ltd.

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Huons Co., Ltd.'s market cap?

Huons Co., Ltd.'s market capitalization is KRW 210.31B.

Does Huons Co., Ltd. pay a dividend?

Huons Co., Ltd. has a dividend yield of 6.5%.

What does Huons Co., Ltd. do?

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory.